Application of CD36 inhibitor in preparation of medicine for inhibiting scar formation after spinal cord injury

The invention provides an application of a CD36 inhibitor in preparation of a medicine for inhibiting scar formation after spinal cord injury, relates to the technical field of biology, and in particular relates to an application of the CD36 inhibitor in a medicine for repairing nerve injury. According to the application, 100 microliters of three CD36 inhibitor salvianolic acid B (50 g/ml, 100 g/ml and 200 g/ml) are injected into the intraperitoneal cavity by utilizing a spinal cord T10 half-cut model, and after 8 weeks, fiber scars formed by aggregation of damaged local fibroblasts can be obviously inhibited, and meanwhile, regeneration of damaged local blood vessels is also promoted. The important effect of the plant extract in the nerve injury repairing process can be better understood, and a new target spot is provided for treatment after nerve injury. 本发明提供CD36抑制剂在制备抑制脊髓损伤后疤痕形成药物中的应用，涉及生物技术领域，具体涉及CD36抑制剂在修复神经损伤药物中的应用。本发明利用脊髓T10半切模型，经腹腔注射三种剂量CD36抑制剂丹酚酸B（50,100和200µg/ml）100微升，8周后，发现可以显著抑制损伤局部成纤维细胞聚集形成的纤维疤痕